TNDM director Sandra Beaver files Form 3 with no share holdings
Rhea-AI Filing Summary
Tandem Diabetes Care, Inc. director Sandra Beaver filed an initial statement of beneficial ownership of securities. As of the event date of 11/07/2025, the filing reports beneficial ownership of 0 shares of common stock of Tandem Diabetes Care, Inc., held directly. The filing also shows no derivative securities, such as options or warrants, currently reported as beneficially owned.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Beaver Sandra
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 0 shares (Direct)
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Tandem Diabetes Care (TNDM) disclose in this Form 3 filing?
The Form 3 reports that director Sandra Beaver beneficially owns 0 shares of Tandem Diabetes Care common stock as of 11/07/2025 and lists no derivative securities.
Who is the reporting person in this TNDM Form 3 filing?
The reporting person is Sandra Beaver, who is identified in the filing as a director of Tandem Diabetes Care, Inc.
Are there any options or other derivative securities reported for TNDM in this Form 3?
No. The table for derivative securities contains no entries, indicating no derivative securities are reported as beneficially owned in this filing.
Is this Form 3 for one reporting person or a group for Tandem Diabetes Care (TNDM)?
The filing is indicated as Form filed by One Reporting Person, meaning it covers only the holdings of director Sandra Beaver.